Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Relypsa

Explore full profile

Biopharmaceutical company developing drugs for treating cardiovascular and renal diseases

Redwood City, United StatesFounded 2007Biotech & Life Sciences
Valuation $16M Market cap · 2012
Revenue $19M Latest reported FY

About Relypsa

Relypsa, a subsidiary of Vifor Pharma since September 1, 2016, specializes in the discovery, development, and delivery of therapeutics that utilize polymer science and other novel approaches. The company's core product is patiromer for oral suspension, the first commercialized medicine resulting from their polymer technology platform. Relypsa operates in the pharmaceutical market, primarily serving patients with hyperkalemia, a condition characterized by elevated potassium levels in the blood. The business model focuses on the development and commercialization of innovative therapeutics, generating revenue through the sale of its patented medicines. By leveraging advanced polymer science, Relypsa aims to address unmet medical needs and improve patient outcomes.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2007
Headquarters
Redwood City, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • 5AM Ventures
  • Sprout Group
  • Mediphase Venture Partners
  • New Leaf Venture Partners
  • CMEA Capital
  • Delphi Ventures
  • OrbiMed

Series B and later3 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Redwood City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Relypsa on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Relypsa on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles